Paper Details

  1. Home
  2. Paper Details

Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.

Author: DekantRaphael, HuYanmei, SneydHannah, WangJun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Influenza virus infection is a serious health threat that leads to thousands of deaths and millions of hospitalizations annually. Current anti-influenza drugs are limited by drug resistance. This review highlights the influenza virus nucleoprotein (NP) as a promising drug target for the development of next-generation antivirals with broad-spectrum activity and a high genetic barrier to resistance.
Paper Details　
Original Abstract of the Article :
Prevention and treatment of influenza virus infection is an ongoing unmet medical need. Each year, thousands of deaths and millions of hospitalizations are attributed to influenza virus infection, which poses a tremendous health and economic burden to the society. Aside from the annual influenza sea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/28240183

データ提供：米国国立医学図書館（NLM）

Influenza A Virus Nucleoprotein: A Target in the Desert of Antiviral Drug Development

We're trekking through the vast desert of virology, searching for new weapons to fight the ever-evolving influenza virus. This study is like a research team meticulously exploring the landscape of influenza A virus, seeking new targets for antiviral drugs. They're focusing on the nucleoprotein, a crucial component of the virus, and exploring its potential as a target for new antiviral therapies. The study aims to find a way to outsmart the virus and develop drugs that can effectively inhibit its replication.

Nucleoprotein: A New Frontier in Influenza Treatment

The study highlights the potential of targeting the influenza A virus nucleoprotein as a strategy for developing new antiviral drugs. It's like finding a new oasis in the desert of antiviral drug development, offering a promising new pathway for tackling this widespread and potentially deadly infection. The study emphasizes the need for continuous research and development of new antivirals, especially in light of the emergence of drug-resistant influenza strains.

Battling the Flu: A Fight Against an Evolving Enemy

This study emphasizes the importance of staying ahead of the influenza virus, which is constantly evolving and becoming resistant to current antiviral treatments. It's like a battle against a wily desert bandit who is always changing his tactics. The study highlights the need for ongoing research and development of new antiviral strategies, especially in light of the emergence of drug-resistant influenza strains.

Dr.Camel's Conclusion

The desert of influenza virus infection is a treacherous place, but with ongoing research and development, we can find new weapons to fight this deadly enemy. This study points to a promising new target – the influenza A virus nucleoprotein – and offers hope for the future of antiviral drug development. It's a reminder that the battle against viruses is a continuous one, requiring constant vigilance and innovation.
Date :
  1. Date Completed 2017-08-16
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

28240183

DOI: Digital Object Identifier

NIHMS968165

Related Literature

Article Analysis
・Effects of rimantadine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.